Get the Stockscreener App
6.50
2.99%
-0.20
After Hours:
6.53
0.03
+0.46%
Optinose Inc Stock (OPTN) Forecast
The Optinose Inc (OPTN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.012, representing a -84.43% decrease from the current price of $6.50. The highest analyst price target is $1.9939, and the lowest is $0.03.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month OPTN Price Target
Average 1.6217
(-75.05% Downside)
Is Optinose Inc (OPTN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.82 | Neutral |
| STOCH(9,6) | 60.12 | Neutral |
| STOCHRSI(14) | 86.46 | Sell |
| MACD(12,26) | -0.4706 | Buy |
| ADX(14) | 31.97 | Sell |
| William %R | -42.74 | Neutral |
| CCI(14) | 13.81 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.2847
Buy
|
6.4727
Buy
|
| MA20 |
6.7867
Sell
|
6.7586
Sell
|
| MA50 |
8.0982
Sell
|
8.0019
Sell
|
| MA100 |
10.33
Sell
|
9.9764
Sell
|
| MA200 |
13.64
Sell
|
12.69
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, OPTN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on OPTN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.82 indicates that OPTN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 60.12 indicates that OPTN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 86.46 indicates that OPTN is oversold. This suggests that OPTN price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.97 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 13.81 indicates that OPTN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term OPTN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Optinose Inc financial reports and earnings history, Optinose Inc (OPTN) stock could reach $10.08 by 2030, $5.6875 by 2040 and $18.93 by 2050. See the projected annual prices until 2050 of the Optinose Inc stock below:
- Optinose Inc (OPTN) is expected to reach an average price of $1.9159 in 2035, with a high prediction of $2.1217 and a low estimate of $2.0059. This indicates an $-70.52% rise from the last recorded price of $6.50.
- Optinose Inc (OPTN) stock is projected to chart a bullish course in 2040, with an average price target of $5.7747, representing an $-11.16% surge from its current level. The forecast ranges from a conservative $5.8047 to a sky-high $5.6875.
- Our analysts predict Optinose Inc (OPTN) to jump 55.07% by 2045, soaring from $10.09 to an average price of $10.08, potentially reaching $9.9632. While $10.09 is the low estimate, the potential upside is significant.
- Optinose Inc (OPTN) stock is expected to climb by 2050, reaching an average of $19.01, a $192.53% jump from its current level. However, a wide range of estimates exists, with high and low targets of $18.93 and $18.89, respectively, highlighting the market's uncertainty.
Optinose Inc Stock (OPTN) Year by Year Forecast
Optinose Inc Stock (OPTN) Price Forecast for 2025
Optinose Inc Stock (OPTN) is expected to reach an average price of $1.6217 in 2025, with a high prediction of $3.2133 and a low estimate of $0.03. This indicates an -75.05% fall from the last recorded price of $6.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $0.1909 | $0.03 | $1.9939 | -97.06% |
| March, 2025 | $1.5512 | $0.5421 | $0.7479 | -76.14% |
| April, 2025 | $2.9764 | $2.2742 | $3.2133 | -54.21% |
| May, 2025 | $3.2635 | $3.4485 | $3.1955 | -49.79% |
| June, 2025 | $3.2556 | $3.1676 | $3.0145 | -49.91% |
| July, 2025 | $0.7508 | $1.7358 | $2.5236 | -88.45% |
| August, 2025 | $2.7979 | $0.7368 | $3.0282 | -56.96% |
| September, 2025 | $0.18 | $1.65 | $1.467 | -97.23% |
| October, 2025 | $2.3652 | $1.773 | $2.1052 | -63.61% |
| November, 2025 | $2.6773 | $2.3912 | $2.4773 | -58.81% |
| December, 2025 | $3.2324 | $2.6533 | $2.6724 | -50.27% |
Optinose Inc Stock (OPTN) Price Forecast for 2026
The predicted value for Optinose Inc (OPTN) in 2026 is set at an average of $2.0299. Estimates vary from a peak of $2.5388 to a trough of $1.5209, indicating an -68.77% surge from the present price of $6.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0546 | $2.1845 | $2.3155 | -68.39% |
| February, 2026 | $2.0567 | $2.0337 | $1.9392 | -68.36% |
| March, 2026 | $1.9188 | $1.9588 | $1.7358 | -70.48% |
| April, 2026 | $1.664 | $1.5209 | $1.7718 | -74.40% |
| May, 2026 | $2.1661 | $2.077 | $2.0332 | -66.68% |
| June, 2026 | $2.2382 | $2.2852 | $2.1021 | -65.57% |
| July, 2026 | $2.4234 | $2.1073 | $2.3434 | -62.72% |
| August, 2026 | $1.8455 | $2.2355 | $2.2955 | -71.61% |
| September, 2026 | $2.4006 | $1.8685 | $2.3606 | -63.07% |
| October, 2026 | $2.6028 | $2.5037 | $2.4397 | -59.96% |
| November, 2026 | $2.2549 | $2.2949 | $2.5388 | -65.31% |
| December, 2026 | $2.03 | $2.105 | $2.1879 | -68.77% |
Optinose Inc Stock (OPTN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Optinose Inc (OPTN) is $1.6295, with a high forecast of $3.1134 and a low forecast of $0.1457. This indicates an -74.93% decrease from the last price of $6.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.0922 | $1.9791 | $1.9222 | -67.81% |
| February, 2027 | $3.2343 | $2.2682 | $2.2843 | -50.24% |
| March, 2027 | $2.9894 | $3.1294 | $3.1134 | -54.01% |
| April, 2027 | $2.4816 | $2.8616 | $2.9055 | -61.82% |
| May, 2027 | $2.0537 | $2.2627 | $2.2746 | -68.40% |
| June, 2027 | $1.6088 | $1.4658 | $1.7067 | -75.25% |
| July, 2027 | $1.751 | $1.761 | $1.8324 | -73.06% |
| August, 2027 | $1.8931 | $1.6613 | $1.5431 | -70.88% |
| September, 2027 | $1.8982 | $1.9461 | $1.9452 | -70.80% |
| October, 2027 | $0.4503 | $1.8703 | $1.8713 | -93.07% |
| November, 2027 | $0.0775 | $0.1894 | $0.3775 | -98.81% |
| December, 2027 | $0.1324 | $0.1457 | $0.2953 | -97.96% |
Optinose Inc Stock (OPTN) Price Forecast for 2028
In 2028, Optinose Inc (OPTN) is projected to reach an average price of $0.6692, with a high projection of $1.3352 and a low estimate of $0.00328. This indicates an -89.70% fall from the last price of $6.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.0903 | $0.00328 | $0.6993 | -98.61% |
| February, 2028 | $0.2481 | $0.00722 | $0.5368 | -96.18% |
| March, 2028 | $0.213 | $0.0651 | $0.3501 | -96.72% |
| April, 2028 | $1.2891 | $0.1301 | $1.2191 | -80.17% |
| May, 2028 | $1.3443 | $1.4043 | $1.3352 | -79.32% |
| June, 2028 | $1.2164 | $1.2404 | $1.1073 | -81.29% |
| July, 2028 | $1.1485 | $1.1355 | $1.0715 | -82.33% |
| August, 2028 | $0.9737 | $1.0007 | $1.0266 | -85.02% |
| September, 2028 | $0.7158 | $0.7948 | $0.7898 | -88.99% |
| October, 2028 | $0.4679 | $0.7679 | $0.6349 | -92.80% |
| November, 2028 | $1.1231 | $0.781 | $1.0701 | -82.72% |
| December, 2028 | $0.9952 | $1.1052 | $1.0411 | -84.69% |
Optinose Inc Stock (OPTN) Price Forecast for 2029
The 2029 price forecast for Optinose Inc Stock (OPTN) is $3.2527 on average, with a high prediction of $6.4936 and a low estimate of $0.0117. This represents an -49.96% decrease from the previous price of $6.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.8854 | $0.9704 | $1.0143 | -86.38% |
| February, 2029 | $0.7075 | $0.7625 | $0.7634 | -89.12% |
| March, 2029 | $0.5046 | $0.6746 | $0.6555 | -92.24% |
| April, 2029 | $0.5267 | $0.6137 | $0.5307 | -91.90% |
| May, 2029 | $0.4019 | $0.4719 | $0.4828 | -93.82% |
| June, 2029 | $0.264 | $0.294 | $0.3149 | -95.94% |
| July, 2029 | $0.1261 | $0.2457 | $0.2531 | -98.06% |
| August, 2029 | $0.0213 | $0.0117 | $0.1917 | -99.67% |
| September, 2029 | $0.3866 | $0.0174 | $0.5166 | -94.05% |
| October, 2029 | $0.5914 | $0.423 | $1.0614 | -90.90% |
| November, 2029 | $0.0365 | $0.0365 | $0.6284 | -99.44% |
| December, 2029 | $7.8436 | $0.0326 | $6.4936 | +20.67% |
Optinose Inc Stock (OPTN) Price Forecast for 2030
Optinose Inc Stock (OPTN) is expected to reach an average price of $8.7901 in 2030, with a high forecast of $11.33 and a low forecast of $6.2518. This signifies an +35.23% surge from the last price of $6.50.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.33 | $8.2597 | $10.08 | +58.98% |
| February, 2030 | $9.0982 | $10.48 | $9.6721 | +39.97% |
| March, 2030 | $11.75 | $11.11 | $11.16 | +80.81% |
| April, 2030 | $9.2166 | $10.54 | $11.33 | +41.79% |
| May, 2030 | $9.2869 | $8.9809 | $9.1888 | +42.88% |
| June, 2030 | $8.3862 | $8.6362 | $9.2291 | +29.02% |
| July, 2030 | $6.2915 | $6.7515 | $8.0923 | -3.21% |
| August, 2030 | $5.9557 | $6.5876 | $6.1936 | -8.37% |
| September, 2030 | $7.30 | $6.2518 | $7.16 | +12.31% |
| October, 2030 | $8.2503 | $6.8721 | $7.5266 | +26.93% |
| November, 2030 | $10.25 | $8.3614 | $9.4745 | +57.76% |
| December, 2030 | $11.19 | $10.75 | $10.62 | +72.14% |
0.58%
2.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):